The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
At Asembia’s AXS25 Summit, Shea Hudson spotlighted how pharmacists are transforming into essential clinical partners through advanced technology, patient advocacy, and value-based collaboration.
Adjuvant Treatment for HER2+ Early Breast Cancer Receives FDA Approval
May 4th 2019The FDA rapidly reviewed and approved Genentech’s application under the FDA’s Real-Time Oncology Review (RTOR) and Assessment Aid pilot programs, leading to an approval 12 weeks after completing the submission.
Read More
New Data Support Viral Suppression as Key to Preventing HIV Transmission
May 3rd 2019Results of the recent study, published in The Lancet, support the benefits of early testing and treatment for HIV, as well as the message of Prevention Access Campaign’s U=U (undetectable equals untransmittable) initiative.
Read More
Importance of Patient Provider Communication
May 3rd 2019Lisa Holle, PharmD, BCOP, FHOPA, associate clinical professor at the University of Connecticut, explains the importance of patient-provider communication during the 2019 Hematology/Oncology Pharmacy Association conference in Fort Worth, Texas.
Watch
Ivosidenib as Monotherapy Granted FDA Approval for Certain Patients with IDH1 Mutant AML
May 3rd 2019The sNDA was granted Priority Review and accepted under the agency's Real-Time Oncology Review pilot program, which aims to make the review of oncology drugs more efficient by allowing the FDA access to clinical trial data before the information is formally submitted to the agency.
Read More
Factors Driving Pharmacists into Primary Care
May 2nd 2019During the 2019 American Society of Consultant Pharmacists (ASCP) Forum in Washington, DC, Johanna M. Thompson, PhamD, BCPS, BCGP, clinical pharmacist at Intermountain Healthcare, discusses one of the factors that drive pharmacists into the primary care field.
Watch
Providers to Need to Consider Patient-Specific Factors in Treating CLL
May 2nd 2019In this clip from the Hematology/Oncology Pharmacy Association, Alison Duffy, PharmD, BCOP, from the University of Maryland Greenbaum Comprehensive Cancer Center, shares important considerations in treating Chronic Lymphocytic Leukemia in patients.
Watch
Mental Health First Aid, administered by the National Council for Behavioral Health, trains participants in mental health literacy, understanding risk factors and warning signs for mental health and addiction concerns and strategies for how to help someone in both crisis and non-crisis situations.
Read More
Bipolar Disorder: Opportunity for Pharmacists to Improve Adherence and Health Outcomes
As highly accessible health care professionals, pharmacists have the opportunity to improve medication adherence and health outcomes of patients with bipolar disorder.
Read More
First Treatment for All Genotypes of Hepatitis C in Pediatric Patients Granted FDA Approval
April 30th 2019The safety and efficacy of the glecaprevir and pibrentasvir in pediatric patients was evaluated during clinical trials of 47 patients with genotype 1, 2, 3 or 4 HCV infection without cirrhosis or with mild cirrhosis.
Read More
Study Shows Drug May Be New Treatment Option for Pediatric Patients with T2D
April 29th 2019Novo Nordisk announced the results of the ELLIPSE trial, which examined efficacy and safety and demonstrated superiority of liraglutide (Victoza) injection 1.8 mg vs placebo, in a presentation at the Pediatric Endocrine Society (PES)/Pediatric Academic Societies (PAS) Annual Meeting in Baltimore, MD, on Sunday.
Read More